Extrahepatic Manifestations in Patients with Chronic Hepatitis C

Chronic hepatitis C virus infection often has autoimmune clinical and analytic features. This review analyzes recent data on the close association of chronic hepatitis C virus infection with autoimmune and lymphoproliferative processes.

Recent Findings

Hepatitis C virus infection has been associated with both organ-specific (thyroiditis, diabetes) and systemic autoimmune diseases.

Experimental, virologic, and clinical evidence has demonstrated a close association between hepatitis C virus infection and Sjogren syndrome, with hepatitis C virus-associated Sjogren syndrome being indistinguishable in most cases from the primary form.

With respect to rheumatoid arthritis, patients with hepatitis C virus-related polyarthritis and positive rheumatoid factor may fulfill the classification criteria for rheumatoid arthritis.

Hepatitis C virus has also been associated with an atypical presentation of antiphospholipid syndrome, as well as with the development of sarcoidosis.

A higher prevalence of hematologic processes in patients with hepatitis C virus infection has recently been reported, including cytopenias and lymphoproliferative disorders.

Recent data are available on the use of new immunosuppressive and biologic agents (mainly mycophenolate mofetil, anti-tumor necrosis factor agents, and rituximab) in patients with hepatitis C virus infection and autoimmune or lymphoproliferative manifestations.

Summary

There is increasing evidence of a close association of hepatitis C virus infection with autoimmune and hematologic processes.

The sialotropism of hepatitis C virus may explain the close association with Sjogren syndrome, and its lymphotropism links the virus to cryoglobulinemia, autoimmune cytopenias, and lymphoma.

The substantial overlap between cryoglobulinemic features and the classification criteria for some systemic autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, and polyarteritis nodosa) make the differentiation between mimicking and coexistence difficult.

Department of Autoimmune Diseases, Institut d'Investigacions Biomediques August Pi i Sunyer, School of Medicine, University of Barcelona, Hospital Clinic, Barcelona, Spain.

06/20/05

Reference
M Ramos-Casals and J Font. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Current Opinions on Rheumatology 17(4): 447-455. July 2005.

Additional Articles on Extrahepatic Events


FDA-approved
HCV Treatments


——

Experimental
HCV Treatments


——

Index of All
Hepatitis C
Articles by Topic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HIV AND AIDS
| HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH
|
TESTS | INTERNET CONFERENCE REPORTS | LINKS | ABOUT US | CONTACT US